Navigation Links
Sentinelle Medical Receives Frost & Sullivan Excellence in Technology Award
Date:3/24/2009

TORONTO, March 24 /PRNewswire/ - Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and software has been honoured with Frost & Sullivan's 2009 North American Excellence in Technology Award (within the MRI Scanners Market). Sentinelle receives this Award in recognition of the tremendous success of its Vanguard 1.5T breast imaging coils product line in 2008, highlighted by a number of exclusive distribution agreements secured with leading MRI manufacturers.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices.

"Breast cancer will impact 200,000 women in North America this year. Sentinelle was founded with the goal of providing the most powerful tools to support radiologists, technologists, and oncologists in their efforts for earlier detection and improved treatment of cancer. Our approach has been to work with leading clinicians to understand and address the challenges they face in new and innovative ways," said Cameron Piron, Sentinelle's President and CEO. "This past year has been extremely rewarding for the Sentinelle team. Not only have we been able to partner with MRI market leaders like GE, Siemens and Toshiba, but we are being recognized for our innovations with this prestigious Award."

"Sentinelle's Vanguard technologies significantly improve the diagnostic capabilities and patient comfort for Breast MRI," said Frost & Sullivan Industry Analyst Travis Chong. "Sentinelle has quickly gained recognition as a technology leader with its advanced ergonomic Vanguard design and adjustable visco-elastic padding that enables clinicians to achieve greater image resolution and improved patient management. With clear improvements to both the form and function of an MRI auxiliary table, it's no wonder why the company has achieved tremendous growth within the emerging Breast MRI market."

The Frost & Sullivan Excellence in Technology Award is bestowed upon a company that has pioneered the development and introduction of an innovative technology into the market. The award recognizes a company's successful technology development that is expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. It also recognizes the company's overall technical excellence and its commitment toward technology innovation.

About Sentinelle Medical Inc.

Sentinelle Medical is dedicated to improving patient care with early detection and accurate intervention. The company researches, develops, manufactures, sells and supports leading edge Magnetic Resonance (MR) technologies. The ground breaking Sentinelle Vanguard Breast MR Auxiliary Table(R) provides excellent quality MR images, complete and open access for intervention and award winning design that optimizes patient comfort and workflow. Sentinelle products are used in leading breast cancer sites throughout North America including Dartmouth-Hitchcock Medical Centre, H. Lee Moffitt Cancer Center and Research Institute (University of South Florida), Scripps Memorial Hospital, Sunnybrook Health Sciences Centre and University Health Network. Sentinelle Medical is a privately owned Canadian company.

For more information, visit www.sentinellemedical.com.


'/>"/>
SOURCE Sentinelle Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sentinelle Medical Enters OEM Distribution Agreement with Toshiba
2. Sentinelle Medical Enters OEM Distribution Agreement with Siemens AG
3. MSU engineering team designs innovative medical device
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
6. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
9. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
10. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
11. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... Swirl: A Wine Tasting Event in New York City, with long-time partners The ...
(Date:12/4/2016)... ... ... While James Earl Jones is known for myriad roles on stage and ... Page". One of the forthcoming episodes examines mammogram techniques; a very important part of ... due to early detection. Like any other disease, treatments have a much higher chance ...
(Date:12/4/2016)... , ... December 03, 2016 , ... ... growing Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual ... Hotel, presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded ...
(Date:12/4/2016)... Newport Beach, CA (PRWEB) , ... December 04, ... ... youthful appearance without undergoing major cosmetic surgery can now take advantage of a ... is an advanced skin rejuvenation treatment that reduces the appearance of age spots, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... , Dec. 2, 2016 In the ... sources apart from those derived from C. sativa, the ... Universita` di Napoli Federico II , the Universita` ... the first comprehensive, critical, integrated and unified inventory of ... article focuses on the remarkable chemical and structural ...
(Date:12/2/2016)... INDIANAPOLIS , Dec. 2, 2016  Eli Lilly ... its financial guidance for 2017 and provide updated financial ... will also conduct a conference call on that day ... the company,s financial guidance. The conference call ... the general public can access a live webcast of ...
Breaking Medicine Technology: